Senyawa Alami sebagai Kandidat Obat Antikanker: Suatu Tinjauan Kimia Medisinal
DOI:
https://doi.org/10.61132/obat.v3i6.1865Keywords:
anticancer, natural products, medicinal chemistry, QSAR, SARAbstract
Cancer remains a major challenge in modern medicine due to drug resistance and the adverse effects of conventional therapies, making it one of the leading causes of death worldwide. Continuous scientific efforts aim to discover safer and more effective treatments. Owing to their structural diversity, strong bioactivity, and relatively low toxicity, natural compounds show great promise as sources of anticancer drug candidates. This article aims to explore the role of medicinal chemistry in investigating, modifying, and optimizing natural bioactive compounds to develop more effective, selective, and stable anticancer agents with improved bioavailability. A narrative review was conducted using scientific literature published between 2020 and 2025 from PubMed, ScienceDirect, Google Scholar, and ResearchGate. The findings indicate that eugenol, berberine, hesperidin, piperine, and quercetin exhibit anticancer activities through apoptosis induction, inhibition of proliferation, and antioxidant and anti-inflammatory mechanisms. Modern medicinal chemistry relies on understanding structure–activity relationships (SAR), chemical modification, and nanoparticle formulation to enhance biological performance. In addition, in silico techniques such as molecular docking and QSAR analysis are applied to study ligands and receptors and predict bioavailability improvements. The development of natural products as rational, effective, and safe anticancer drug candidates is strengthened by integrating experimental, computational, and pharmaceutical approaches.
Downloads
References
Abdi Syahputra, R., Dalimunthe, A., Utari, Z. D., Halim, P., Sukarno, M. A., Zainalabidin, S., Salim, E., Gunawan, M., Nurkolis, F., Park, M. N., Luckanagul, J. A., Bangun, H., Kim, B., & Harahap, U. (2024). Nanotechnology and flavonoids: Current research and future perspectives on cardiovascular health. Journal of Functional Foods, 120(April), 106355. https://doi.org/10.1016/j.jff.2024.106355
Amin, S., & Guspiana, R. (2025). Tinjauan kimia medisinal potensi ekstrak minyak atsiri cengkeh (Syzygium aromaticum) bagi kesehatan. Journal of Public Health Science, 2(2), 153–159. https://doi.org/10.70248/jophs.v2i2.2194
Amin, S., Heryanto, P., Athaya, R., & Fitri, N. A. (2024). Perkembangan terkini dalam desain obat berbasis kimia medisinal. Jurnal Ilmu Medis Indonesia, 4(1), 93–100. https://doi.org/10.35912/jimi.v4i1.4558
Amin, S., Nuraeni, T., Nisa, F. F., & Khoirunnisa, A. (2025). Desain senyawa alami dari daun sirih sebagai kandidat obat antikanker berdasarkan pendekatan kimia medisinal. Journal of Innovative and Creativity, 5(3), 35–43.
Amin, S., Yunarsih, Y., Ririhani, I., Miraz, Y., Amelia, N., & Rizki, M. (2025). Tinjauan kimia medisinal dalam pengembangan obat berbasis bahan alam: Studi literatur. Jurnal Ners, 9(2), 3010–3016. https://doi.org/10.31004/jn.v9i2.44620
Asma, S. T., Acaroz, U., Imre, K., Morar, A., Shah, S. R. A., Hussain, S. Z., Arslan-Acaroz, D., Demirbas, H., Hajrulai-Musliu, Z., Istanbullugil, F. R., Soleimanzadeh, A., Morozov, D., Zhu, K., Herman, V., Ayad, A., Athanassiou, C., & Ince, S. (2022). Natural products/bioactive compounds as a source of anticancer drugs. Cancers, 14(24). https://doi.org/10.3390/cancers14246203
Auti, A., Tathode, M., Marino, M. M., Vitiello, A., Ballini, A., Miele, F., Mazzone, V., Ambrosino, A., & Boccellino, M. (2024). Nature’s weapons: Bioactive compounds as anti-cancer agents. AIMS Public Health, 11(3), 747–772. https://doi.org/10.3934/publichealth.2024038
Bano, N., Parveen, S., Saeed, M., Siddiqui, S., Abohassan, M., & Mir, S. S. (2024). Drug repurposing of selected antibiotics: An emerging approach in cancer drug discovery. ACS Omega, 9(25), 26762–26779. https://doi.org/10.1021/acsomega.4c00617
Challapa-Mamani, M. R., Tomás-Alvarado, E., Espinoza-Baigorria, A., León-Figueroa, D. A., Sah, R., Rodriguez-Morales, A. J., & Barboza, J. J. (2023). Molecular docking and molecular dynamics simulations related to Leishmania donovani: An update and literature review. Tropical Medicine and Infectious Disease, 8(10), 1–13. https://doi.org/10.3390/tropicalmed8100457
Emens, L. A., Romero, P. J., Anderson, A. C., Bruno, T. C., Capitini, C. M., Collyar, D., Gulley, J. L., Hwu, P., Posey, A. D., Silk, A. W., & Wargo, J. A. (2024). Challenges and opportunities in cancer immunotherapy: A Society for Immunotherapy of Cancer (SITC) strategic vision. Journal for ImmunoTherapy of Cancer, 12(6), 1–15. https://doi.org/10.1136/jitc-2024-009063
Esmeeta, A., Adhikary, S., Dharshnaa, V., Swarnamughi, P., Maqsummiya, Z. U., Banerjee, A., Pathak, S., & Duttaroy, A. K. (2022). Plant-derived bioactive compounds in colon cancer treatment: An updated review. Biomedicine & Pharmacotherapy, 153, 113384. https://doi.org/10.1016/j.biopha.2022.113384
Febriyanti, R. M., Rafif, S. N., Mikdar, N. N., Hikmatiana, B. N., Maisyarah, I. T., Khatib, A., & Muhaimin, M. (2025). Anticancer potential of bioactive compounds in Premna serratifolia, Premna odorata, and Premna tomentosa: A review of in vitro evidence. Cancer Management and Research, 17(May), 1029–1045. https://doi.org/10.2147/CMAR.S516204
Kementerian Kesehatan Republik Indonesia. (2024). Rencana Kanker Nasional 2024–2034. Kementerian Kesehatan Republik Indonesia.
Koirala, M., & DiPaola, M. (2024). Overcoming cancer resistance: Strategies and modalities for effective treatment. Biomedicines, 12(8), 1–19. https://doi.org/10.3390/biomedicines12081801
Li, H., Han, S., Dong, C., & Liu, Z. (2024). Advancements in conventional cancer therapy combined with immunotherapy. Endoscopic Ultrasound. https://doi.org/10.1097/ot9.0000000000000067
Pellegrini, E., & Stringaro, A. (2024). A review.
Ramadiyana. (2021). Indonesian Research Journal on Education, 4, 550–558.
Ranjbar, S., Emamjomeh, A., Sharifi, F., Zarepour, A., Aghaabbasi, K., Dehshahri, A., Mohammadi Sepahvand, A., Zarrabi, A., Beyzaei, H., Zahedi, M. M., & Mohammadinejad, R. (2023). Lipid-based delivery systems for flavonoids and flavonolignans: Liposomes, nanoemulsions, and solid lipid nanoparticles. Pharmaceutics, 15(7). https://doi.org/10.3390/pharmaceutics15071944
Saeful, A., Amelia, N. P., Ramadhan, T. O., & Putri, S. D. (2025). Pendekatan kimia medisinal dalam optimasi senyawa bioaktif dari bahan alam sebagai kandidat obat antikanker. Jurnal Riset Rumpun Ilmu Kedokteran, 4(1), 51–60. https://doi.org/10.55606/jurrike.v4i1.4430
Sun, Y., Li, Q., Huang, Y., Yang, Z., Li, G., Sun, X., Gu, X., Qiao, Y., Wu, Q., Xie, T., & Sui, X. (2024). Natural products for enhancing the sensitivity or decreasing the adverse effects of anticancer drugs through regulating the redox balance. Chinese Medicine, 19(1), 1–33. https://doi.org/10.1186/s13020-024-00982-2
Szczepański, J., Tuszewska, H., & Trotsko, N. (2022). Anticancer profile of rhodanines: Structure–activity relationship (SAR) and molecular targets—A review. Molecules, 27(12). https://doi.org/10.3390/molecules27123750
Taghizadeh, M. S., Niazi, A., Moghadam, A., & Afsharifar, A. (2022). Experimental, molecular docking and molecular dynamic studies of natural products targeting overexpressed receptors in breast cancer. PLoS ONE, 17(5), 1–14. https://doi.org/10.1371/journal.pone.0267961
Tang, P. M. K., & Zhang, D. (2023). Advance in targeted cancer therapy and mechanisms of resistance. International Journal of Molecular Sciences, 24(23), 10–13. https://doi.org/10.3390/ijms242316584
Tesya, A. (2020). Potensi metabolit aktif dalam sayuran cruciferous untuk menghambat pertumbuhan sel kanker. Jurnal Penelitian Perawat Profesional, 2(November), 459–472.
Vasilev, B., & Atanasova, M. (2025). A comprehensive review of the application of quantitative structure–activity relationship (QSAR) in the prediction of new compounds with anti-breast cancer activity. Applied Sciences, 15(3). https://doi.org/10.3390/app15031206
Wang, Y., Wang, F., Liu, W., Geng, Y., Shi, Y., Tian, Y., Zhang, B., Luo, Y., & Sun, X. (2024). New drug discovery and development from natural products: Advances and strategies. Pharmacology & Therapeutics, 264, 108752. https://doi.org/10.1016/j.pharmthera.2024.108752
Zafar, A., Khatoon, S., Khan, M. J., Abu, J., & Naeem, A. (2025). Advancements and limitations in traditional anti-cancer therapies: A comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy. Discover Oncology, 16(1). https://doi.org/10.1007/s12672-025-02198-8
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 OBAT: Jurnal Riset Ilmu Farmasi dan Kesehatan
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
